Sanofi re­ports sales growth amid Dupix­en­t's Chi­na launch, but re­veals PDU­FA de­lay in Pompe dis­ease pro­gram

Sanofi re­leased its first quar­ter earn­ings re­port Wednes­day, and while the com­pa­ny saw pos­i­tive news re­gard­ing growth and sales — par­tic­u­lar­ly in Chi­na — they al­so re­vealed …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER